【24h】

Intra-articular Diagnostic Injection Exhibits Poor Predictive Value for Outcome After Hip Arthroscopy

机译:髋关节镜检查后关节内诊断注射对结果的预测价值较差

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: To determine whether the amount of pain relief after preoperative intra-articular (IA) anesthetic injection predicts clinical and functional outcomes after hip arthroscopy, especially when controlling for the presence of chondral degeneration. Methods: We identified patients who underwent IA injection and subsequent hip arthroscopy for labral pathology between 2007 and 2013 performed by a single surgeon. Inclusion criteria were ultrasound- or fluoroscopic-guided IA anesthetic injection performed at our institution, prospectively documented pre- and postinjection numerical rating scale pain scores, and minimum 1-year follow-up postoperatively. Patients were divided into 2 groups, those who received >50% pain relief from preoperative IA anesthetic injection and those who received <= 50% relief. Preoperative radiographs were reviewed, and degree of osteoarthritis was determined using the Tonnis classification system. Outcomes were assessed with Modified Harris Hip Score and Hip Outcome Score (HOS). Univariate and multivariate models were performed to assess whether percent pain relief correlated with outcome. Results: Of the 319 arthroscopic hip surgeries performed between 2007 and 2013, 115 (37%) patients were lost to follow-up, 16 (5%) patients did not receive an IA injection, 16 (5%) patients had an injection containing gadolinium, and 40 (13%) patients completed injections at an outside institution. Five (2%) patients were excluded for a history of ipsilateral hip surgery, and 3 (1%) for a history of contralateral hip surgery, leaving 96 hips in 96 patients. There were 71 females (74%) and 25 males (26%) with a mean age of 37.6 +/- 14.0 years. Tonnis was grade 0, 1, and 2 for 26 (27%), 55 (56%), and 16 (17%) patients, respectively. Fifty-one (53%) of the injections contained a corticosteroid. The mean pain relief after IA injection was 73% +/- 36% (range, 0% to 100%). Twenty-six hips (26%) had <= 50% pain relief, whereas 70 (73%) had >50% pain relief, and the median time interval from injection to surgery was 3 (range, <1 to 20) months. Outcome scores were obtained at a mean 14.8 (range, 11 to 30) months after arthroscopic surgery. Postoperative mean Modified Harris Hip Score, HOS activities of daily living, and HOS-Sport scores were 79.2 +/- 17.3, 82.6 +/- 17.3, and 67.4 +/- 28.2, respectively. There was no statistical correlation between percent pain relief and outcome. There was no significant difference in outcome scores between those with <= 50% and >50% pain relief. Multivariate regression analysis showed no significant predictors of outcome, including age, gender, Tonnis grade, percent relief with IA injection, or type of surgery. Conclusions: In this study of patients undergoing hip arthroscopy for labral pathology, our data indicate that the amount of pain relief from IA injection may be a poor predictor of short-term outcome, even when adjusting for chondral degeneration. Although anesthetic injections can be an important diagnostic tool in select patients, a combination of the clinical history, physical examination, and imaging findings is fundamental.
机译:目的:确定术前关节内(IA)麻醉剂注射后缓解疼痛的量是否可预测髋关节镜检查后的临床和功能结局,尤其是在控制软骨变性的情况下。方法:我们确定了在2007年至2013年间由一名外科医生进行了IA注射和随后的髋关节镜检查以进行实验室病理检查的患者。纳入标准为在我们机构进行的超声或荧光镜引导的IA麻醉注射,前瞻性记录的注射前后数字评分量表疼痛评分以及术后至少1年的随访。患者分为两组,术前IA麻醉注射缓解疼痛> 50%的患者和<= 50%缓解的患者。回顾术前X线照片,并使用Tonnis分类系统确定骨关节炎的程度。结果以改良的Harris髋关节得分和髋关节得分(HOS)进行评估。进行单变量和多变量模型以评估疼痛缓解百分比是否与预后相关。结果:在2007年至2013年间进行的319例关节镜下髋关节手术中,有115例(37%)患者失去了随访,16例(5%)患者未接受IA注射,16例(5%)患者进行了以下注射40和40名(13%)患者在外部机构完成了注射。有5名(2%)患者因同侧髋部手术史而被排除在外,而3名(1%)因对侧髋部手术史而被排除在外,有96名患者中有96髋。有71名女性(74%)和25名男性(26%),平均年龄为37.6 +/- 14.0岁。 Tonnis分别为26(27%),55(56%)和16(17%)患者的0、1和2级。五十一次(53%)注射液中含有皮质类固醇。 IA注射后的平均疼痛缓解率为73%+/- 36%(范围为0%至100%)。 26髋(26%)的疼痛缓解率小于或等于50%,而70髋(73%)的疼痛缓解率大于50%,从注射到手术的中位时间间隔为3(范围为<1至20)个月。关节镜手术后平均14.8(11至30)个月获得结果评分。术后平均改良型Harris髋关节评分,日常生活中的HOS活动和HOS-Sport评分分别为79.2 +/- 17.3、82.6 +/- 17.3和67.4 +/- 28.2。疼痛缓解百分率与预后之间无统计学意义。疼痛缓解率分别为<= 50%和> 50%的患者之间的得分没有显着差异。多元回归分析显示,没有明显的预后指标,包括年龄,性别,Tonnis分级,IA注射缓解百分比或手术类型。结论:在这项针对髋关节镜进行实验室病理检查的患者的研究中,我们的数据表明,即使调整了软骨变性,IA注射减轻疼痛的程度也可能无法预测短期预后。尽管在某些患者中麻醉剂注射可能是重要的诊断工具,但临床病史,体格检查和影像学检查的结合是基础。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号